This treatment taken by many French people is concerning: several patients are going blind after using it!

This treatment promises a dramatic weight loss, but it may cost you your eyesight in return. Several patients have reported sudden vision loss after taking this very popular medication.


A Source of Concern

With over 215,000 users in France, this miracle drug was mainly known for its impressive slimming properties. However, in recent days, it has been in the spotlight for its worrisome side effects, particularly the sudden loss of vision reported by several users.

This was the case for James Norris, a 56-year-old American who shared his terrifying experience in the NYPost: My doctor had just increased the dose. One morning, when I opened my eyes, I could hardly see anything from my left eye. Two weeks later, the same thing happened with my right eye. Today, I am very afraid of losing my sight for good.” His lawyer claims to have received hundreds of similar testimonies.”



The Miracle Medication Turned Nightmare?

The medication in question is Ozempic, renowned for its appetite-suppressing effect and prescribed to over 215,000 French individuals, primarily to manage type 2 diabetes. In recent years, influencers and celebrities have used it as a weight loss solution, often leading to shortages. However, behind these miraculous results may lie a dramatic side effect: ischemic optic neuropathy, a condition that can potentially lead to visual impairment or loss of vision.

In light of the worrisome increase in reported cases in the United States and Europe (a recent scientific study published in the journal Jama Ophthalmology documents several serious complications), The European Medicines Agency has decided to launch a thorough investigation. Although doctors have yet to establish conclusively that Ozempic directly causes these vision losses, they now advise extreme caution and recommend immediate consultation at any sign of eye trouble.

For now, the Novo Nordisk laboratory remains cautious yet reassuring, stating that there is currently no evidence proving the medication’s direct responsibility. Nevertheless, concern is mounting among users and physicians, who recommend extreme vigilance.